CORMORANT ASSET MANAGEMENT, LP purchased 13.2% of their position (1.31M shares) of AMBRX BIOPHARMA, INC. on the open market
Open‑market purchase worth $9.14M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/25/2023ACC: 0000929638-23-002829
10% Owner
Since Oct 2023
+1.31M
Net shares
Net buyer
$9.14M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.31M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.31M
Price / share
$6.99
Trade value
$9.14M
% of position
13.2%
10/23/2023
9.92M→11.23M
Total
Net shares
+1.31M
Net value
$9.14M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/23/2023 | P · Purchase | +1.31M | $6.99 | $9.14M | 13.2% | 9.92M | 11.23M |
| Total | +1.31M | $9.14M | ||||||
Derivative Transactions0
No derivative transactions reported